Novartis AG
Utility Patent Applications
Last updated:
List of all Novartis AG patents 676 in total
| Status | Patent |
|---|---|
Application | Utility: USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: CRYSTALLINE FORMS OF A TRIAZOLOPYRIMIDINE COMPOUND Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: NOVEL HETEROARYL BUTANOIC ACID DERIVATIVES Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: GFRAL EXTRACELLULAR DOMAINS AND METHODS OF USE Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: Pharmaceutical Compositions and Pharmaceutical Products of Heterodimeric Human Interleukin-15 (hetIL-15) Filling date: 23 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS Filling date: 23 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS Filling date: 23 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BE- NZYL]-AZETIDINE-3-CARBOXYLIC ACID Filling date: 23 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: UREA COMPOUNDS AND COMPOSITIONS AS SMARCA2/BRM ATPASE INHIBITORS Filling date: 23 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES Filling date: 23 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: ENHANCED ANTIGEN PRESENTING ABILITY OF RNA CAR T CELLS BY CO-INTRODUCTION OF COSTIMULATORY MOLECULES Filling date: 23 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: USE OF IL-1 BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE Filling date: 23 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: MEANS AND METHOD FOR PRODUCING AND PURIFYING VIRAL VECTORS Filling date: 23 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: METHODS FOR PREVENTING AND TREATING HEART DISEASE Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INHBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: NLRP3 INFLAMMASOME INHIBITORS Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS Filling date: 23 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: CRYSTALLINE FORMS OF A LTA4H INHIBITOR Filling date: 23 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: USE OF IL-1BETA BINDING ANTIBODY CANAKINUMAB FOR TREATING OR ALLEVATING SYMPTOMS PULMONARY SARCOIDOSIS Filling date: 23 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: NOVEL REGIMES OF FXR AGONISTS Filling date: 23 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: SYRINGE Filling date: 23 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: HIGH-THROUGHPUT MULTI-ORGAN PERFUSION MODELS Filling date: 23 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS OF LIPOIC ACID CHOLINE ESTER SALTS AND METHODS OF TREATMENT USING SAME Filling date: 23 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: NOVEL NAPHTHYRIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ARRHYTHMIA Filling date: 23 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: MRNA-MEDIATED IMMUNIZATION METHODS Filling date: 23 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: METHODS FOR TREATING OCULAR SURFACE PAIN Filling date: 23 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: ANTIBODY FORMULATION Filling date: 23 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: CHEMICAL PROCESS FOR PREPARING PHENYLPIPERIDINYL INDOLE DERIVATIVES Filling date: 23 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: MDM2 INHIBITORS AND COMBINATIONS THEREOF Filling date: 23 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS Filling date: 23 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: CYCLIC TETRAMER COMPOUNDS AS PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS Filling date: 23 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: GDF-15 AS A HAEMATOLOGICAL TOXICITY BIOMARKER Filling date: 23 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES Filling date: 23 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: CELL-BASED ASSAY FOR MEASURING DRUG PRODUCT POTENCY Filling date: 23 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carbo- xamide Derivatives Filling date: 23 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: CHO CELL EXPRESSED HET IL-15 Filling date: 23 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: GDF-15 AS A HAEMATOLOGICAL TOXICITY BIOMARKER Filling date: 23 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: IMMUNE-STIMULATING HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2, AND FUSION PROTEINS THEREOF Filling date: 23 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF IMMUNE CELLS Filling date: 23 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists Filling date: 23 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: Pyridine and Pyrazine Derivative for the Treatment of CF Filling date: 23 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: IMMUNE-STIMULATING MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2 Filling date: 23 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS Filling date: 23 Sep 2025 Issue date: 29 Jul 2021 |
Showing 150 to 200 of 676 patents.